PlainRecalls
FDA Drug Moderate Class II Ongoing

Lisdexamfetamine Dimesylate Capsules, 60 mg, CII, 100-count bottles, Rx only, Manufactured by: OHM Laboratories, New Brunswick, NJ 08901, Distributed by: Sun Pharmaceuticals, Inc., Cranbury, NJ 08512, NDC 57664-051-88

Reported: July 23, 2025 Initiated: June 16, 2025 #D-0516-2025

Product Description

Lisdexamfetamine Dimesylate Capsules, 60 mg, CII, 100-count bottles, Rx only, Manufactured by: OHM Laboratories, New Brunswick, NJ 08901, Distributed by: Sun Pharmaceuticals, Inc., Cranbury, NJ 08512, NDC 57664-051-88

Reason for Recall

Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 9 month long term stability station (25¿C, 60%RH).

Details

Units Affected
5,448 bottles
Distribution
Recalled units were distributed to 17 distributors who may have further distributed the product nationwide.
Location
Princeton, NJ

Frequently Asked Questions

What product was recalled?
Lisdexamfetamine Dimesylate Capsules, 60 mg, CII, 100-count bottles, Rx only, Manufactured by: OHM Laboratories, New Brunswick, NJ 08901, Distributed by: Sun Pharmaceuticals, Inc., Cranbury, NJ 08512, NDC 57664-051-88. Recalled by SUN PHARMACEUTICAL INDUSTRIES INC. Units affected: 5,448 bottles.
Why was this product recalled?
Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 9 month long term stability station (25¿C, 60%RH).
Which agency issued this recall?
This recall was issued by the FDA Drug on July 23, 2025. Severity: Moderate. Recall number: D-0516-2025.